Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new keppra clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on keppra
- Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Status: Recruiting, Condition Summary: Epilepsy - Keppra to Improve Chronic Aphasia
Status: Recruiting, Condition Summary: Aphasia; Stroke; Amnesia - A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
Status: Completed, Condition Summary: Epilepsy; Childhood Absence Epilepsy; Seizures - Long Term Follow-up Study With Levetiracetam XR (Keppra XR) for Partial Seizures
Status: Enrolling by invitation, Condition Summary: Epilepsy - An Open Long Term Follow up Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
Status: Active, not recruiting, Condition Summary: Epilepsies, Partial - Efficacy of Levetiracetam in Essential Tremor
Status: Completed, Condition Summary: Essential Tremor - Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis
Status: Recruiting, Condition Summary: Epileptic Seizures; Stroke - Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175
Status: Completed, Condition Summary: Epilepsy - Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures.
Status: Active, not recruiting, Condition Summary: Epilepsy, Partial - Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Status: Recruiting, Condition Summary: Epilepsy - Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Status: Recruiting, Condition Summary: Epilepsy - Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old
Status: Completed, Condition Summary: Epilepsy - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Status: Completed, Condition Summary: Epilepsy - Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
Status: Completed, Condition Summary: Epilepsy, Partial - Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
Status: Completed, Condition Summary: Epilepsy - Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
Status: Completed, Condition Summary: Generalized Epilepsy - Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
Status: Completed, Condition Summary: Idiopathic Parkinson Disease - A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
Status: Completed, Condition Summary: Epilepsy, Partial - Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
Status: Completed, Condition Summary: Epilepsy, Tonic-Clonic - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
Status: Completed, Condition Summary: Epilepsy, Tonic-Clonic - Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Status: Completed, Condition Summary: Epilepsy, Partial - A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
Status: Completed, Condition Summary: Absence Seizures - Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
Status: Completed, Condition Summary: Epilepsy, Partial - A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
Status: Completed, Condition Summary: Neuralgia, Postherpetic - A Study to Look at the Efficacy and Safety of Keppra® Extended Release
Status: Completed, Condition Summary: Epilepsy - Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Status: Completed, Condition Summary: Epilepsy - Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-Therapy in Subjects With Partial Epilepsy
Status: Completed, Condition Summary: Epilepsy - A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Status: Completed, Condition Summary: Epilepsy - Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy
Status: Completed, Condition Summary: Epilepsy - Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
Status: Completed, Condition Summary: Bipolar Disorder